The Economic Freedom Fighters (EFF) party is demanding the immediate resignation of South Africa's Health Minister, Dr. Aaron Motsoaledi, following a Pretoria High Court ruling that found irregularities in the R15.5 billion national antiretroviral (ARV) tender. The court's judgment, delivered on October 20 by Acting Judge Graham Girdwood, declared that the awards for Item 13 and Item 23, worth R12.6 billion, were unlawful and unconstitutional.

The court case was brought by Cipla Medpro Manufacturing, one of South Africa's oldest local ARV producers. The judgment found that Innovata Pharmaceuticals and Viatris Healthcare used an expired manufacturing site license at their Isando facility before the tender closure. As a result, both companies have been disqualified from reconsideration. Furthermore, the court discovered that Barrs Pharmaceuticals and Innovata, both subsidiaries of Avacare Health Group, submitted prices with only a R1 difference for one product, raising concerns about possible collusion.

The EFF party had previously raised concerns about the tender process in February, with MP Naledi Chirwa warning Motsoaledi about the potential irregularities. The party now demands a Special Investigating Unit (SIU) investigation into the matter, the suspension of all officials involved, and the restarting of the tender process. The EFF also criticized Motsoaledi for distancing himself from the procurement process, stating that he relied on officials to handle the tenders.

Cipla Medpro Manufacturing, which received only minor awards worth between R214 million to R215 million despite having the capacity to supply over half the national demand for TLD, welcomed the court's judgment. The company stated that it approached the court not for commercial gain but to ensure that the tender rewards proven, licensed local capacity and complies with the Constitution. Cipla argued that Item 13 and 23 are the same medicine in different packs and should not have been split to exclude capable local producers.

The Department of Health has welcomed the judgment, assuring patients of an uninterrupted supply of ARVs. The department stated that clinics and hospitals will continue dispensing ARVs as current suppliers remain contracted during the 120-day reallocation period. Department spokesperson Foster Mohale said the department will comply with the court's order to reconsider the tender within 120 days and implement internal controls to address licensing verification and HDI documentation issues raised.

The court's ruling also ordered Motsoaledi and his then Director General to pay Cipla's costs. The EFF party's demand for Motsoaledi's resignation has been rejected by the Department of Health, with Mohale stating that such calls are "just a political statement, not the position of parliament." The department has assured that it will implement measures to prevent similar irregularities in the future.

The R15.5 billion ARV tender scandal has significant implications for South Africa's healthcare system, with the EFF party calling for accountability and transparency in the procurement process. The court's judgment has vindicated Cipla's long track record at its Durban facility, and the company has expressed satisfaction with the outcome. The Department of Health has committed to ensuring that the ARV supply chain remains uninterrupted during the reallocation period.

Key points

  • The Pretoria High Court found irregularities in the R15.5 billion national antiretroviral tender, declaring that the awards for Item 13 and Item 23 were unlawful and unconstitutional.
  • The EFF party is demanding the immediate resignation of Health Minister Dr. Aaron Motsoaledi, a Special Investigating Unit investigation, and the restarting of the tender process.
  • The Department of Health has welcomed the judgment, assuring patients of an uninterrupted supply of ARVs and committing to implement measures to prevent similar irregularities in the future.

Reporting sources

Share this story

Written by

SaharaWire Newsroom
SaharaWire

Reporting for SaharaWire from the Nairobi bureau.